A Pilot Study of Biomarkers of Stress in Youth Who Use Teens.Connect
1 апреля 2019 г. обновлено: Yale University
This feasibility/pilot study has three purposes.
First, the investigators will determine the feasibility of collecting saliva to measure stress biomarkers over three days at home in youth.
Second, the investigators will conduct a pilot study of the Teens.Connect Internet program for youth with type 1 diabetes to determine whether changes in stress biomarkers associate with self-reported perceived stress and HbA1c.
Third, the investigators will examine the gene-environment interaction of the top 14 targeted candidate genes and epi-genome wide effects of teens' stress biomarkers and its influence on blood glucose levels over time.
Обзор исследования
Статус
Завершенный
Условия
Вмешательство/лечение
Подробное описание
Intensive management of type 1 diabetes (T1D) among youth as recommended by the American Diabetes Association requires a complex set of self-management activities that create high levels of perceived stress in youth and families. In individuals exposed to chronic stress, such as that of a chronic condition, the body responds with physiological and hormonal responses to adapt. These responses can be harmful (e.g., higher glucose levels, higher HbA1c). Such harmful effects may be ameliorated by programs that reduce psychosocial stress.
The investigators have found an Internet-delivered coping skills training program combined with a diabetes education program significantly improved HbA1c and QOL for youth with T1D. Self-reported perceived stress mediated these outcomes. There has been little to no examination, however, of whether a reduction in self-reported perceived stress is associated with a reduction in biochemical markers of stress which could explain the positive impact on HbA1c. It is critically important to understand the physiologic as well as the psychosocial mechanisms associated with such interventions in order to improve glycemic control in youth with this chronic autoimmune condition. If such interventions affect biomarkers of stress, it would be important to strengthen the stress reduction activities embedded in such interventions, such as meditation, to further improve metabolic control. Thus, aims of this pilot/feasibility study are to:
- Determine the feasibility and reliability of collection of saliva for the measurement of three stress biomarkers at awakening and 30-45 minutes later over 3 days at home in 20 youth (age 11-14 years). These biomarkers include cortisol to assess hypothalamic-pituitary-adrenal axis functioning; alpha-amylase (s-AA) to assess the sympathetic-adrenal-medullary system, and salivary immunoglobulin A (s-IgA) to assess stress-related immune changes. This aim will allow the investigators to determine the feasibility of recruiting youth to provide such data in a larger trial by assessing the percent of youth who agree to participate and adhere to the salivary collection protocol, using actigraphy to document awakening time and Medication Event Monitoring System (MEMS) caps monitoring to determine time of salivary collection. Patterns and variability of stress biomarker levels over 3 days will be used to assess intra-individual variability and relationships with self-reported daily stressors and self-reported perceived stress.
- Conduct a pilot study of Teens.Connect, a combination of the investigators' previous TEENCOPE™ and Managing Diabetes programs with 40 youth to determine whether alterations in stress biomarkers are associated with self-reported perceived stress and HbA1c.
- Assess epigenetic components of these responses by examining the gene-environment interaction of the top 14 targeted candidate genes and epigenome wide effects of teens' stress biomarkers and their influence on HbA1c levels over time. Candidate genes will be measured at baseline and DNA methylation patterns will be measured at baseline and then again at 6 months follow-up using the Oragene saliva collection kits.
Тип исследования
Интервенционный
Регистрация (Действительный)
29
Фаза
- Непригодный
Контакты и местонахождение
В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.
Места учебы
-
-
Connecticut
-
West Haven, Connecticut, Соединенные Штаты, 06516-7399
- Yale School of Nursing
-
-
Критерии участия
Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.
Критерии приемлемости
Возраст, подходящий для обучения
От 11 лет до 14 лет (Ребенок)
Принимает здоровых добровольцев
Нет
Полы, имеющие право на обучение
Все
Описание
Inclusion Criteria:
- diagnosed with T1D for at least 6 months;
- age 11 to 14 years
- naïve to TEENCOPE and/or Managing Diabetes
- assent and parent/guardian consent to participate in the study
Exclusion Criteria:
- medical condition that impacts cortisol functioning
- takes medications that impact cortisol, except diabetes medications
- sleeps less than 6 hours per night
- smokes
- takes oral contraceptives
Учебный план
В этом разделе представлена подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Teens.Connect
The Teens-Connect internet-based program has two complementary components - TEENCOPE and Managing Diabetes.
Managing Diabetes consists of 5 sessions on educational content related to diabetes self management targeted to adolescents.
TEENCOPE consists of a series of 5 sessions designed to increase children's sense of competence and mastery by retraining inappropriate or non-constructive coping styles and forming more positive styles and patterns of behavior.
Each week a new 30-45 minute session is uploaded to a password-protected website on the Yale server for youth to complete.
Youth are grouped with 8-12 peers who complete the same weekly sessions in an asynchronous manner.
Youth interact with each other on an online discussion board moderated by a clinical psychologist.
|
Teens.Connect combines two internet psycho-educational programs, TEENCOPE™, an internet version of coping skills training using a graphic novel format combined with social media, and an internet diabetes problem-solving educational program (Managing Diabetes)
|
|
Без вмешательства: Control
Wait listing will serve as the control condition.
Usual care at the Yale Pediatric Diabetes Center consists of quarterly visits with physicians and nurse practitioners, accessibility to nutritional and psychological consultation, and 24/7 on call service.
Following completion of the 6 month data point, youth will be offered the opportunity to participate in the internet program.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Glycosylated Hemoglobin (HbA1c)
Временное ограничение: baseline
|
Bayer Diagnostics DCA2000® (normal range = 4.2-6.3%)
|
baseline
|
|
Glycosylated Hemoglobin (HbA1c)
Временное ограничение: 6 months
|
Bayer Diagnostics DCA2000® (normal range = 4.2-6.3%)
|
6 months
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Perceived Stress Scale
Временное ограничение: baseline
|
A 14-item scale that measures the degree to which situations in one's life are appraised as stressful.
Items assess feelings of stress, hassles, and coping during the past month.
Respondents rate items on a 5-point Likert scale ranging from 0 (never) to 4 (very often), with higher scores indicative of greater perceived stress and less effective coping.
|
baseline
|
|
Perceived Stress Scale
Временное ограничение: 6 months
|
A 14-item scale that measures the degree to which situations in one's life are appraised as stressful.
Items assess feelings of stress, hassles, and coping during the past month.
Respondents rate items on a 5-point Likert scale ranging from 0 (never) to 4 (very often), with higher scores indicative of greater perceived stress and less effective coping.
|
6 months
|
|
Adolescent Stress Questionnaire (ASQ)
Временное ограничение: baseline
|
A 94-item inventory of common adolescent stressors.
Each item (stressor) is rated on a 5-point Likert scale where 1=Not at all stressful (or is irrelevant to me); 2=A little stressful; 3=Moderately stressful; 4=Quite stressful; and 5=Very stressful.
|
baseline
|
|
Adolescent Stress Questionnaire (ASQ)
Временное ограничение: 6 months
|
A 94-item inventory of common adolescent stressors.
Each item (stressor) is rated on a 5-point Likert scale where 1=Not at all stressful (or is irrelevant to me); 2=A little stressful; 3=Moderately stressful; 4=Quite stressful; and 5=Very stressful.
|
6 months
|
|
Responses to Stress Questionnaire for Diabetes (RSQ)
Временное ограничение: baseline
|
A 69-item scale asking the participant to report frequency of diabetes related stressors (12 items) and their responses to those stressors (57 items).
Frequencies are reported on a 4-point scale ranging from 0 (never) to 3 (almost every day) for stressors, and 1 (not at all) to 4 (a lot) for stress responses.
|
baseline
|
|
Responses to Stress Questionnaire for Diabetes (RSQ)
Временное ограничение: 6 months
|
A 69-item scale asking the participant to report frequency of diabetes related stressors (12 items) and their responses to those stressors (57 items).
Frequencies are reported on a 4-point scale ranging from 0 (never) to 3 (almost every day) for stressors, and 1 (not at all) to 4 (a lot) for stress responses.
|
6 months
|
|
Stress Biomarkers
Временное ограничение: over 3 days at baseline
|
cortisol, alpha-amylase (s-AA), and salivary immunoglobulin A (s-IgA) determined by salivary collection at awakening and 30-45 minutes later over 3 days
|
over 3 days at baseline
|
|
Stress Biomarkers
Временное ограничение: over 2 days at 6 months
|
cortisol, alpha-amylase (s-AA), and salivary immunoglobulin A (s-IgA) determined by salivary collection at awakening and 30-45 minutes later over 2 days
|
over 2 days at 6 months
|
|
Awakening and sleep time
Временное ограничение: over 3 days at baseline
|
wrist-worn accelerometer
|
over 3 days at baseline
|
|
Awakening and sleep time
Временное ограничение: over 2 days at 6 months
|
wrist-worn accelerometer
|
over 2 days at 6 months
|
|
Genotype & DNA Methylation
Временное ограничение: baseline
|
Saliva collection
|
baseline
|
|
DNA Methylation
Временное ограничение: 6 months
|
Saliva collection
|
6 months
|
Соавторы и исследователи
Здесь вы найдете людей и организации, участвующие в этом исследовании.
Спонсор
Соавторы
Следователи
- Главный следователь: Margaret Grey, DrPH, RN, Yale School of Nursing
- Главный следователь: Jacquelyn Taylor, PhD, PNP-BC, Yale School of Nursing
Даты записи исследования
Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.
Изучение основных дат
Начало исследования (Действительный)
8 февраля 2017 г.
Первичное завершение (Действительный)
28 февраля 2019 г.
Завершение исследования (Действительный)
28 февраля 2019 г.
Даты регистрации исследования
Первый отправленный
18 ноября 2016 г.
Впервые представлено, что соответствует критериям контроля качества
18 ноября 2016 г.
Первый опубликованный (Оценивать)
22 ноября 2016 г.
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
2 апреля 2019 г.
Последнее отправленное обновление, отвечающее критериям контроля качества
1 апреля 2019 г.
Последняя проверка
1 апреля 2019 г.
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- 1503015414
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
НЕТ
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Нет
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Нет
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .